Literature DB >> 18849758

Health care costs among individuals with chronic obstructive pulmonary disease within several large, multi-state employers.

Theodore Darkow1, Benjamin J Chastek, Hemal Shah, Amy L Phillips.   

Abstract

OBJECTIVE: To estimate chronic obstructive pulmonary disease (COPD)-attributable medical resource utilization and health care costs among employed individuals and their covered dependents with COPD.
METHOD: Retrospective health care claims analysis. Employees and dependents 40 to 63 years old with a diagnosis of COPD between January 1, 2001 and December 31, 2002 were matched to two separate control cohorts. Medical resource utilization and health care costs were compared between cohorts.
RESULTS: A total of 6445 individuals with COPD were matched to each control cohort. Mean age was 55.1 years, and cohorts were approximately 50% men. COPD subjects had significantly higher utilization and adjusted pharmacy, medical, and total health care costs than both control cohorts (P < 0.001).
CONCLUSIONS: COPD subjects had significantly higher utilization and costs than individuals without COPD. Thus, the economic burden of COPD is present in younger, working individuals, as well as in the older, retired population.

Entities:  

Mesh:

Year:  2008        PMID: 18849758     DOI: 10.1097/JOM.0b013e31818837c8

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  5 in total

1.  The burden of chronic obstructive pulmonary disease among employed adults.

Authors:  Marco daCosta DiBonaventura; Ryne Paulose-Ram; Jun Su; Margaret McDonald; Kelly H Zou; Jan-Samuel Wagner; Hemal Shah
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-03-19

Review 2.  The impact of digital health interventions on health-related outcomes in the workplace: A systematic review.

Authors:  Ana Howarth; Jose Quesada; Jessica Silva; Stephanie Judycki; Peter R Mills
Journal:  Digit Health       Date:  2018-05-10

3.  Healthcare costs of patients with chronic obstructive pulmonary disease in Denmark - specialist care versus GP care only.

Authors:  Jesper Lykkegaard; Jesper Bo Nielsen; Maria Munch Storsveen; Dorte Ejg Jarbøl; Jens Søndergaard
Journal:  BMC Health Serv Res       Date:  2022-03-28       Impact factor: 2.655

4.  The assessment of new drugs for asthma and COPD: a Delphi study examining the perspectives of Italian payers and clinicians.

Authors:  Silvia Sommariva; Aureliano P Finch; Claudio Jommi
Journal:  Multidiscip Respir Med       Date:  2016-01-27

5.  Economic burden of COPD in a Swedish cohort: the ARCTIC study.

Authors:  Karin Lisspers; Kjell Larsson; Gunnar Johansson; Christer Janson; Madlaina Costa-Scharplatz; Jean-Bernard Gruenberger; Milica Uhde; Leif Jorgensen; Florian S Gutzwiller; Björn Ställberg
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.